GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » PS Ratio
中文

Neurocrine Biosciences (BSP:N1BI34) PS Ratio : 7.63 (As of Apr. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Neurocrine Biosciences PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Neurocrine Biosciences's share price is R$35.68. Neurocrine Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was R$4.68. Hence, Neurocrine Biosciences's PS Ratio for today is 7.63.

Warning Sign:

Neurocrine Biosciences Inc stock PS Ratio (=7.51) is close to 1-year high of 7.55

The historical rank and industry rank for Neurocrine Biosciences's PS Ratio or its related term are showing as below:

BSP:N1BI34' s PS Ratio Range Over the Past 10 Years
Min: 5.58   Med: 20.02   Max: 3963.64
Current: 7.27

During the past 13 years, Neurocrine Biosciences's highest PS Ratio was 3963.64. The lowest was 5.58. And the median was 20.02.

BSP:N1BI34's PS Ratio is ranked worse than
86.27% of 1005 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs BSP:N1BI34: 7.27

Neurocrine Biosciences's Revenue per Sharefor the three months ended in Dec. 2023 was R$1.24. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was R$4.68.

During the past 12 months, the average Revenue per Share Growth Rate of Neurocrine Biosciences was 24.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 28.40% per year.

During the past 13 years, Neurocrine Biosciences's highest 3-Year average Revenue per Share Growth Rate was 262.40% per year. The lowest was -76.10% per year. And the median was 21.60% per year.

Back to Basics: PS Ratio


Neurocrine Biosciences PS Ratio Historical Data

The historical data trend for Neurocrine Biosciences's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences PS Ratio Chart

Neurocrine Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.05 8.96 7.36 7.93 7.05

Neurocrine Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.93 6.21 5.59 6.29 7.05

Competitive Comparison of Neurocrine Biosciences's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Neurocrine Biosciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurocrine Biosciences's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurocrine Biosciences's PS Ratio distribution charts can be found below:

* The bar in red indicates where Neurocrine Biosciences's PS Ratio falls into.



Neurocrine Biosciences PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Neurocrine Biosciences's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=35.68/4.677
=7.63

Neurocrine Biosciences's Share Price of today is R$35.68.
Neurocrine Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Neurocrine Biosciences  (BSP:N1BI34) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Neurocrine Biosciences PS Ratio Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurocrine Biosciences (BSP:N1BI34) Business Description

Traded in Other Exchanges
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (BSP:N1BI34) Headlines

No Headlines